Literature DB >> 23850056

SGLT2 inhibitors for diabetes: turning symptoms into therapy.

Michaela Diamant1, Linde M Morsink.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23850056     DOI: 10.1016/S0140-6736(13)60902-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Treatment of type 2 diabetes, lifestyle, GLP1 agonists and DPP4 inhibitors.

Authors:  Gerald H Tomkin
Journal:  World J Diabetes       Date:  2014-10-15

Review 2.  Sodium-glucose cotransporter 2 (SGLT-2) inhibitors: a new antidiabetic drug class.

Authors:  Paula Nogueira da Silva; Raissa Alves da Conceição; Rodolfo do Couto Maia; Maria Leticia de Castro Barbosa
Journal:  Medchemcomm       Date:  2018-06-06       Impact factor: 3.597

Review 3.  Dapagliflozin for the treatment of type 2 diabetes: a review of the literature.

Authors:  Mujahid A Saeed; Parth Narendran
Journal:  Drug Des Devel Ther       Date:  2014-12-10       Impact factor: 4.162

4.  Influence of Familial Renal Glycosuria Due to Mutations in the SLC5A2 Gene on Changes in Glucose Tolerance over Time.

Authors:  Emilia Ottosson-Laakso; Tiinamaija Tuomi; Björn Forsén; Monika Gullström; Per-Henrik Groop; Leif Groop; Petter Vikman
Journal:  PLoS One       Date:  2016-01-06       Impact factor: 3.240

Review 5.  Postprandial Glucose Spikes, an Important Contributor to Cardiovascular Disease in Diabetes?

Authors:  Nordin M J Hanssen; Michael J Kraakman; Michelle C Flynn; Prabhakara R Nagareddy; Casper G Schalkwijk; Andrew J Murphy
Journal:  Front Cardiovasc Med       Date:  2020-09-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.